好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2017 Annual Meeting | C236 - Assessment of Rapidly Progressive Dementias I: Overview, Prion Diseases, and Neurodegenerative Rapidly Progressive Dementia

Friday 04/28/17
01:00 PM - 03:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Michael D. Geschwind, MD, PhD, FAAN
Participants should be familiar with the differential diagnosis of prion and other neurodegenerative disease causes of RPD and the clinical presentation and evaluation of the more common conditions.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider
Case-based, Didactic, Audience Participation
Event Timeline
01:00 PM - 01:05 PM Luncheon Introduction
Michael D. Geschwind, MD, PhD, FAAN
01:05 PM - 02:05 PM Speaker Approach to Rapidly Progressive Dementia and Clinical Overview of Prion Diseases
Michael D. Geschwind, MD, PhD, FAAN
02:05 PM - 02:50 PM Speaker Non-prion Neurodegenerative Diseases Presenting as Rapidly Progressive Dementia
Bradley F. Boeve, MD, FAAN
02:50 PM - 03:00 PM Q&A Questions and Answers
Faculty Disclosures
Michael D. Geschwind, MD, PhD, FAAN Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.